
Ciaran O'Leary, BlueYard
Origins - Inside Venture Capital, Hosted by a GP and an LP
Exploring a Revolutionary Portfolio Company and Speculating on Blue Yard's Future
Exploring a portfolio company programming stem cells for animal-free food and new therapies, with potential for industry disruption. The discussion extends to Blue Yard's future, emphasizing their boutique nature and pursuit of cutting-edge technologies like quantum control chips.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.